Benefit-Risk Assessment of Rofecoxib in
โ
Helmut Schmidt, Barry G. Woodcock, Professor Dr Gerd Geisslinger
๐
Article
๐
2004
๐
Springer International Publishing AG
๐
English
โ 137 KB